JP2008009517A - System and method for supporting sale of medicine, and program - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To display risks associated with medicines. <P>SOLUTION: A POS terminal 20 has a medicine-component correspondence table 253 for storing component codes identifying components included in medicines 10 in association with medicine codes identifying the medicines 10, and a component database 25 for storing risk levels representing levels of risk associated with the medicines 10 including the components in association with the component codes. The POS terminal 20 reads a JAN code of a medicine 10 to be sold via a scanner 21, identifies the medicine code associated with the JAN code read, and acquires the component code associated with the identified medicine code from the medicine-component correspondence table 253. The POS terminal 20 further reads out the risk level associated with the acquired component code from the component database 252 and displays it on a display 22. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

  The present invention relates to a pharmaceutical sales support system, a sales support method, and a program.

Information about pharmaceuticals is displayed at the time of sales of pharmaceuticals using a POS (Point Of Sales) terminal or the like. For example, Patent Document 1 discloses a system that displays the name of a drug that is about to be sold.
JP 2003-233673 A

  In recent years, information about pharmaceutical risks has been demanded due to an increase in health consciousness. However, the system described in Patent Document 1 does not consider pharmaceutical risks and cannot display pharmaceutical risks. Therefore, the risk of drugs must be judged based on the knowledge and experience of pharmacists. However, it is difficult to grasp the risk of each large quantity of medical products.

  The present invention has been made in view of such a background, and an object of the present invention is to provide a medicine sales support system, a sales support method, and a program capable of displaying a risk of a medicine.

  The invention according to claim 1 of the present invention for solving the above-mentioned problem is a pharmaceutical sales support system, and specifies a component contained in the drug in association with a drug code specifying the drug. A drug component database for storing a component code; a risk database for storing a risk level indicating a risk level of the drug containing the component in association with the component code; and the drug for specifying the drug to be sold The sales medicine input unit that accepts the input of the code, and the risk that the ingredient code corresponding to the accepted medicine code is read from the medicine ingredient database, and the risk degree corresponding to each of the read ingredient codes is read from the risk database An acquisition unit and an information display for displaying the read risk level on a display device And be provided with, and.

  According to the sales support system of the present invention, since the risk about the medicine to be sold is displayed, the salesperson can refer to the displayed risk and inform the purchaser of the risk. Thereby, the informed consent with respect to a purchaser can be enriched. In addition, a drug purchaser can purchase a drug after confirming the risk.

Moreover, invention of Claim 2 among the present invention is the pharmaceutical sales support system of Claim 1, Comprising: The said risk acquisition part is the most among the said risk degrees corresponding to each of the said component code | cord | chord. Let's read the high one.
In this case, only the largest risk among the risks for each component can be presented as the risk of the drug. Therefore, it is easy to understand because only one risk is displayed as the risk of the medicine.

  The invention according to claim 3 of the present invention is the drug sales support system according to claim 1, and stores medicine explanation information describing the explanation of the medicine in association with the medicine code. A drug information database, a risk information database that stores risk explanation information describing an explanation of the risk of the drug for each risk level, and an explanation information acquisition unit that reads the explanation information corresponding to the received drug code The risk acquisition unit reads the risk explanation information corresponding to the risk degree from the risk information database, and the information display unit displays the risk explanation information and the medicine explanation information. And

Moreover, invention of Claim 4 among the present invention is the pharmaceutical sales support system of Claim 3, Comprising: The information printing part which outputs the said risk explanatory information and the said pharmaceutical explanatory information to a printing apparatus is provided. And
In this case, since the medicine seller can hand over the printed matter to the purchaser together with the verbal explanation based on the display, it is possible to provide more reliable information about the risk of the medicine.

Moreover, invention of Claim 5 among this invention is the pharmaceutical sales support system of Claim 1, Comprising: The said sales pharmaceutical input part receives the input of the list | wrist containing the said some medicine code | cord | chord, A combination contraindication database that stores a contraindication drug code that is a medicine code that identifies the medicine that is contraindicated for use in combination with the medicine specified by the medicine code in association with a medicine code, and the list included in the list For each drug code, the contraindicated drug code corresponding to the drug code is read from the combined contraindication database, and the combined contraindication determination unit that determines whether the read out incompatible drug code is included in the list; and the contraindications If a drug code is included in the list, the drug identified by the drug code; and Combination of the pharmaceutical agent to be identified by the memorial chemicals codes and be provided with a combination contraindicated message display unit to be displayed on said display device a message indicating that is contraindicated.
In this case, in addition to the risk of a single drug, it is possible to provide information on the risk of a combination of multiple drugs.

  Moreover, invention of Claim 6 among the present invention is the pharmaceutical sales support system of Claim 5, Comprising: The said combined contraindication judgment part is the said combined use about each of the said medicine code contained in the said list | wrist. Read the contraindication ID, which is the medicine code corresponding to the contraindication medicine code that matches the medicine code from the contraindication database, determine whether the read contraindication ID is included in the list, and The message display unit displays the combined contraindication message even when the reverse contraindication ID is included in the list.

  According to the present invention, the risk of a medicine can be displayed.

== System configuration ==
Hereinafter, a sales support system for a pharmaceutical product 10 according to an embodiment of the present invention will be described. In the present embodiment, it is assumed that a pharmacist performs face-to-face sales to a user while explaining the pharmaceutical 10 as a salesperson at a pharmacy.

  The overall configuration of the sales support system of this embodiment is shown in FIG. As shown in the figure, the sales support system of the present embodiment includes a POS terminal 20 installed in a store such as a pharmacy. A scanner 21, a display 22, and a printer 23 are connected to the POS terminal 20. The scanner 21 is referred to as a JAN (Japanese Article Number) code assigned to the medicine 10 from the barcode printed on the medicine 10. ). The display 22 displays various types of information such as information related to the pharmaceutical 10 as will be described later. The salesperson refers to the information displayed on the display 22 and explains the drug 10 to the customer. Further, information relating to the medicine 10 is output from the printer 23. In this embodiment, as will be described later, information on the high-risk medicine 10 is output from the printer 23, and the salesperson verbally explains the medicine 10 and hands over the printed matter from the printer 23 to the customer. Can do.

== Configuration of POS Terminal 20 ==
FIG. 2 is a diagram illustrating a hardware configuration of the POS terminal 20. As shown in the figure, the POS terminal 20 includes a CPU 201, a memory 202, a storage device 203, an input interface 204, an output interface 205, a printer interface 206, and a receipt printing device 207.

  The storage device 203 is a hard disk drive, flash memory, CD-ROM drive, or the like that stores programs and data. The CPU 201 implements various functions as the POS terminal 20 by reading the program stored in the storage device 203 into the memory 202 and executing it.

  The input interface 204 is an interface for connecting to a scanner. The input interface 204 acquires a JAN code from the scanner 21 according to a standard such as USB (Universal Serial Bus). The output interface 205 is an interface for connecting to the display 22. As the output interface 205, an analog interface that outputs RGB signals or a digital interface that outputs digital image data can be employed in accordance with the display 22. The printer interface 206 is an interface for connecting to the printer 23. The POS terminal 20 sends information to the printer 23 via the printer interface 206 and prints the information. The receipt printing apparatus 207 is, for example, a thermal printer that prints a receipt of the sold medicine 10.

  FIG. 3 is a diagram showing a software configuration of the POS terminal 20. As shown in the figure, the POS terminal 20 includes a JAN code acquisition unit 211, a risk determination unit 212, a risk display unit 213, a drug information display unit 214, a drug information print unit 215, a drug information input unit 216, a contraindication information acquisition unit. 217, a contraindication information display unit 218, a pharmaceutical database 251, a component database 252, a pharmaceutical component correspondence table 253, and a combined contraindication database 254. Each of the functional units 211 to 218 is realized by the CPU 201 of the POS terminal 20 reading the program stored in the storage device 203 into the memory 202 and executing it. Each of the storage units 251 to 254 is realized as a storage area provided by the memory 202 or the storage device 203 of the POS terminal 20.

  The JAN code acquisition unit 211 acquires the JAN code read from the barcode of the medicine 10 by the scanner 21 via the input interface 204. Note that a method used by a general POS terminal is adopted as a method for the JAN code acquisition unit 211 to receive a JAN code from the scanner 21.

  The drug database 251 stores information related to the drug 10 to be sold in the sales support system of the present embodiment (hereinafter referred to as drug information). FIG. 4 shows a configuration example of drug information stored in the drug database 251. As shown in the figure, the drug information includes a drug code, classification, drug name, unit price, manual file name, image file name, and remarks in association with the JAN code.

  The medicine code is identification information of the medicine 10 assigned to each medicine 10 in the sales support system. The classification of drug information is a classification of drugs, and in this embodiment, it is assumed to be either “marketed drug” or “medical drug”. The drug name is the name of the drug 10, and the unit price is the selling price of the drug 10.

  The instruction file name is a file name of a file (hereinafter referred to as an instruction file) in which an explanation about the medicine 10 is described. In addition, the description about the pharmaceutical 10 is described in the description attached to the pharmaceutical 10. FIG. 5 shows an example of information described in the instruction file (hereinafter referred to as instruction information). As shown in the figure, the contents of the manual information are described for each item such as efficacy, ingredient, usage / capacity. In the description information of this embodiment, as shown in FIG. 5, the contents of each item are described following the name of each item enclosed in parentheses (for example, “product name”, “efficacy / effect”, etc.). A blank line is inserted between the next item. Note that the description format of the instruction information is not limited to the example in FIG. 5, and may be, for example, a table format or an XML format. In other words, any format can be adopted as long as each item can be extracted.

  The component database 252 stores information on components included in the pharmaceutical 10 (hereinafter referred to as component information). FIG. 6 shows a configuration example of component information stored in the component database 252. As shown in the figure, the component information includes a component code, a component name, and a risk level. The component code is identification information for specifying a component. The component name is the name of the component. The degree of risk is a degree of an adverse effect that the pharmaceutical 10 containing this component may have on the human body. In the present embodiment, there are four types of risk degrees “A” to “D”. The degree of risk “A” indicates that the risk of the pharmaceutical 10 containing the component is particularly high, and that active provision of information using a document by a pharmacist and demand for consultation should be obliged to ensure safety. The degree of risk “B” indicates that the risk of the pharmaceutical 10 containing the component is relatively high, and that professionals should actively provide information and require consultation demand. The degree of risk “C” indicates that the risk of the pharmaceutical 10 containing the component is relatively low, and a system centered on demand for consultation by experts should be established. In addition, the degree of risk “D” indicates that there is almost no risk of the pharmaceutical 10 containing the component.

  The drug component correspondence table 253 manages the association of which components are included in the drug 10. A configuration example of the pharmaceutical ingredient correspondence table 253 is shown in FIG. As shown in the figure, the drug component correspondence table 253 stores a drug code indicating the drug 10 and a component code indicating a component included in the drug 10 in association with each other.

== Display of drug information ==
The risk determination unit 212 determines the risk of the pharmaceutical 10 corresponding to the JAN code acquired by the JAN code acquisition unit 211, and the risk display unit 213 displays the risk.
A flow of processing for displaying the risk of the pharmaceutical 10 is shown in FIG. 8 is executed each time the scanner 21 reads the JAN code from the barcode of the medicine 10.

  When the JAN code acquisition unit 211 acquires the JAN code (S301), the risk determination unit 212 reads out drug information corresponding to the JAN code from the drug database 251 (S302), and corresponds to the drug code included in the read drug information. The component code is read from the pharmaceutical component correspondence table 253 (S303).

  The risk determination unit 212 sets the initial value of the risk level (hereinafter referred to as drug risk level) for the drug 10 to be processed to “D” (S304), and corresponds to the component code for each of the above component codes. The risk level to be read is read from the component database 252 (S305), and when the read risk level is larger than the drug risk level (S306: YES), the read risk level is set as the drug risk level (S307).

  The chemical risk level is determined by the above processing. The risk display unit 213 outputs the drug risk level together with the drug information to the display 22 (S308).

An example of the screen 41 displayed by the risk display unit 213 is shown in FIG.
The screen 41 includes a display column 411 for drug information and drug risk. For each JAN code input from the scanner 21, the risk display unit 213 displays the drug risk level determined by the above-described processing of FIG. 8 and the drug code and classification, drug name, unit price, and the like included in the corresponding drug information. Displayed in the display column 411. In the display column 411, the background color of each row may be changed according to the drug risk level.

  The screen 41 also includes a tax amount display column 412 and a total payment display column 413. The risk display unit 213 totals the unit prices of the drug information acquired by the risk determination unit 212 for each drug 10, displays the total amount multiplied by a predetermined consumption tax rate in the display column 412, and displays the total unit price. The total amount obtained by adding the above tax amount is displayed in the display column 413.

  In addition, when any row in the display column 411 of the screen 41 is selected using an input device such as a touch panel or a mouse, drug information about the corresponding drug is displayed on the display 22 by the drug information display unit 214.

  An example of the screen 42 displayed by the medicine information display unit 214 is shown in FIG. As shown in the figure, the screen 42 includes a drug name display field 421, a drug image display field 422, an icon display field 423 according to the drug risk level determined by the risk determination unit 212, a drug risk A degree explanation display field 424, a remarks display field 425, an instruction item designation button 426, and an instruction item display field 427 are provided.

  The drug information display unit 214 displays the drug name and remarks included in the drug information in the display column 421 and the display column 425 of the screen 42, respectively, and image data from the file indicated by the image file name included in the drug information. And an image of the medicine is displayed in the display field 422 based on the read image data.

  The drug information display unit 214 displays an icon indicating that the drug has a risk in the display column 423 when the drug risk level determined by the risk determination unit 212 is “A” to “C”. In addition, the drug information display unit 214 displays an explanation of the risk corresponding to the drug risk level in the display field 424. Table 1 describes the risk corresponding to the chemical risk level. The drug information display unit 214 displays the contents of the explanation column in the table corresponding to the drug risk level on the display column 424 of the screen 42.

  In addition, items of the description information are associated with the selection buttons 426 on the screen 42, and the medicine information display unit 214 extracts the items associated with the pressed selection button 426 from the description information. Are displayed in the display field 427.

  As described above, in the POS terminal 20 of the present embodiment, an explanation about the risk of the medicine 10 to be sold is displayed on the display 22 according to the drug risk level determined by the risk determination unit 212. Accordingly, the salesperson can refer to the display 22 and convey the risk of the medicine 10 to be sold to the purchaser in a face-to-face manner. Therefore, the sales side of the medicine 10 can enhance informed consent for the purchaser. In addition, the purchaser of the pharmaceutical product 10 is relieved to know the risks associated with the pharmaceutical product 10 in advance.

  Further, in the POS terminal 20 of the present embodiment, since the contents described in the instructions for the medicine 10 are displayed on the display 22, the salesperson can display the components, effects, precautions, etc. of the medicine 10 on the display 22. It can be easily grasped from the display. Therefore, a salesperson such as a pharmacist does not need to memorize the components and precautions for each of a wide variety of commercially available medicines 10 and can reduce the burden.

== Printing drug information ==
Next, printing of information related to the pharmaceutical 10 will be described.

  The drug information printing unit 215 prints information such as the drug risk level of the drug 10 from the receipt printing apparatus 207 and the printer 23. In this embodiment, the drug information printing unit 215 prints the drug name and drug risk level from the receipt printing apparatus 207 when the drug risk level is other than “D” (“A” to “C”). An example of the receipt 43 on which the chemical risk is printed is shown in FIG. As shown in the figure, the drug information printing unit 215 prints the drug name 431, the drug risk level 432, and the drug risk level description 433 of the drug information following the purchase details of the receipt 43. Thus, by printing the risk level of the medicine 10 on the receipt 43, the purchaser of the medicine 10 can easily grasp the risk of the medicine 10 purchased.

  In addition, when the drug risk level is “A”, the drug information printing unit 215 prints the instruction information of the drug 10 and the drug risk level from the printer 23. The medicine information printing unit 215 outputs the same information as the screen 42 shown in FIG. Thereby, in addition to the verbal explanation, the salesperson can provide information about the risk of the sold medicine 10 by a document. Therefore, the seller of the medicine 10 can provide information about the medicine 10 to the purchaser more reliably.

== Contraindication of pharmaceutical information ==
Next, the display of risk when a plurality of medicines 10 are used in combination will be described. In general, it is known that the interaction of a plurality of administered medicines 10 may significantly reduce the therapeutic effect or cause various side effects, and such combinations are contraindicated in combination. In the present embodiment, it is determined whether there is a combination that is contraindicated in combination among a plurality of medicines 10 to be purchased.

  The combined contraindication database 254 stores information (hereinafter referred to as contraindication information) related to the pharmaceutical 10 that is contraindicated for combined use. A configuration example of the contraindication information stored in the combined contraindication database 254 is shown in FIG. As shown in the figure, the contraindication information may be associated with the drug code of the drug 10 and used together with the drug 10 to cause side effects or reduce the utility of the drug 10. Drug codes (hereinafter referred to as contraindicated drug codes) that identify the drugs (hereinafter referred to as contraindicated drugs) and explanations of risks associated with the combined use of these drugs. The contraindication information is registered based on the description of the instructions attached to the medicine. If drug B is listed as a contraindicated drug in the instructions attached to drug A, the contraindication information including the drug code indicating drug A and the contraindicated drug code indicating drug B is contraindicated. Registered in the database 254. At the same time, if the drug A is described as a contraindicated drug in the instructions attached to the drug B, the contraindication information including the drug code indicating the drug B and the contraindicated drug code indicating the drug A Is also registered in the combined contraindication database 254.

  The drug information input unit 216 receives an input of a drug code that identifies a drug 10 that is not subject to sale by the sales support system of the present embodiment. The drug code received by the drug information input unit 216 is, for example, a drug code that identifies the drug 10 that the purchaser has already purchased at home, or a drug code of a medical drug that is currently being administered by a doctor.

  The contraindication information acquisition unit 217 reads out the contraindication information that matches the medicine code of the medicinal product 10 to be sold and the medicine code input from the medicine information input unit 216 from the combined contraindication database 254, and the contraindication information display unit 218 The read contraindication information is displayed on the display 22.

  The flow of processing for displaying contraindication information is shown in FIG. An example of a screen 44 on which contraindication information is displayed is shown in FIG.

  The contraindication information acquisition unit 217 creates a list (hereinafter referred to as a drug list) in which the drug code input from the scanner 21 and the drug code received by the drug information input unit 216 are collected (S501). The contraindication information acquisition unit 217 performs the following processing using each medicine code included in the medicine list as a processing medicine code.

  The contraindication information acquisition unit 217 reads out the contraindication information in which the medicine code matches the processing medicine code or the contraindication medicine code matches the processing medicine code from the combined use contraindication database 254 (S502), and the read incontinence information is processed incompatible. The following processing is performed as information.

  The contraindication information acquisition unit 217 determines whether or not the drug code of the processing contraindication information and the contraindication chemical code of the processing contraindication information are included in the drug list, and the drug code of the processing contraindication information is included in the drug list (S503). : YES), and when the contraindicated drug code of the processing contraindication information is included in the drug list (S504: YES), the contraindication information acquisition unit 217 corresponds to the drug code included in the normal contraindication information from the drug database 251. The medicine name to be read is read as medicine name A (S505), and the medicine name corresponding to the contraindicated medicine code included in the contraindication information is read out as medicine name B (S506).

  The contraindication information acquisition unit 217 matches the contraindication information drug code in the contraindication information included in the contraindication list, and the contraindication information in the contraindication information includes the incontinence drug code in the incontinence information. The one that matches the medicine code is acquired (S507).

  When the above contraindication information cannot be acquired (S508: NO), the contraindication information display unit 218 displays the drug name A, “→”, the drug name B, and the normal contraindication in the display field 441 of the screen 44 shown in FIG. The description included in the information is displayed (S509). Here, the arrow “→” from the medicine A to the medicine B displayed as “direction” in the display column 441 was described as a medicine in which the medicine B was contraindicated in the document attached to the medicine A. It shows that.

  On the other hand, when the above contraindication information has been acquired (S508: YES), the contraindication information display unit 218 displays the drug name A, “=”, drug name B, in the display field 441 of the screen 44 shown in FIG. Then, the explanation contained in the processing contraindication information is added with the explanation contained in the acquired contraindication information (S510), and the contraindication information acquisition unit 217 deletes the above contraindication information from the contraindication list (S511). . Here, “=” displayed as “Direction” in the display column 441 is described as a medicine in which the medicine B is contraindicated in the document attached to the medicine A and attached to the medicine B. In the document, the drug A was described as a drug contraindicated for combined use.

  The above processing is performed on each contraindication information in the contraindication list and each medicine code in the medicine list, so that information on the contraindicated medicine is displayed on the screen 44. Therefore, the salesperson of the medicine 10 can check whether there is any combination that is contraindicated in the medicine 10 that is about to be sold. In the case where there is a combination of the contraindicated medicines 10, the salesperson can provide the purchaser with the fact and a related explanation, and can arrange other medicines 10, for example. That is, it is possible to provide more detailed information about the medicine 10 to be sold. Therefore, the purchaser of the medicine 10 is relieved because it can check in advance whether or not there is a combination that is contraindicated in the medicine 10 to be purchased.

  In the example of FIG. 14, the screen 44 includes a check box 442 for selecting a medicine 10 for which a contraindication is checked, and the contraindication information acquisition unit 217 has only the medicine 10 checked in the check box 442. The medicine list may be created. In this case, for example, when there are many combinations of drugs that are contraindicated for concomitant use, by narrowing down the drugs 10 to be checked for concomitant contraindications, the contraindicated information that is displayed at the same time is reduced and the information is easily visually recognized. Can be.

  Although the present embodiment has been described above, the above embodiment is intended to facilitate understanding of the present invention and is not intended to limit the present invention. The present invention can be changed and improved without departing from the gist thereof, and the present invention includes equivalents thereof.

It is a figure showing the whole sales support system composition of this embodiment. 2 is a diagram illustrating a hardware configuration of a POS terminal 20. FIG. 2 is a diagram showing a software configuration of a POS terminal 20. FIG. It is a figure which shows the structural example of the pharmaceutical information memorize | stored in the pharmaceutical database. It is a figure which shows an example of description information. It is a figure which shows the structural example of the component information memorize | stored in the component database. It is a figure which shows the structural example of the pharmaceutical ingredient correspondence table 253. FIG. 6 is a flowchart showing a flow of processing for displaying a risk of a medicine 10. It is a figure which shows an example of the screen 41 displayed by the risk display part 213. FIG. It is a figure which shows an example of the screen 42 which the pharmaceutical information display part 214 displays. It is a figure which shows an example of the receipt 43 on which the information about the pharmaceutical with a risk was printed. It is a figure which shows the structural example of the contraindication information memorize | stored in the combined contraindication database 254. FIG. It is a flowchart which shows the flow of the process by which contraindication information is displayed. It is a figure which shows an example of the screen 44 on which contraindication information is displayed.

Explanation of symbols

10 pharmaceuticals, 20 POS terminals, 21 scanners,
22 displays, 23 printers,
201 CPU, 202 memory, 203 storage device,
204 input interface, 205 output interface,
206 Printer interface, 207 Receipt printing device,
211 JAN code acquisition unit, 212 Risk determination unit,
213 Risk display section, 214 Drug information display section,
215 Drug information printing section, 216 Drug information input section,
217 Contraindication information acquisition part, 218 Contraindication information display part,
251 Pharmaceutical Database, 252 Ingredient Database,
253 Pharmaceutical Component Correspondence Table, 254 Contraindication Concomitant Database,
41 screen, 411 drug risk level display field,
412 Tax amount display field, 413 Total amount display field,
42 screen, 421 drug name display field, 422 image display field,
423 icon display field, 424 drug risk level explanation display field,
425 Remarks display field, 426 Item designation button, 427 Item display field,
43 Receipt, 431 Drug name,
432 Drug risk level, 433 Description of drug risk level,
44 screens, 441 display field, 442 check box

Claims (8)

A pharmaceutical sales support system,
A drug component database that stores a component code that identifies a component included in the drug in association with a drug code that specifies the drug;
A risk database that stores a risk level indicating a risk level of the drug containing the component in association with the component code;
A sales medicine input unit that accepts input of the medicine code for identifying the medicine to be sold;
A risk acquisition unit that reads the component code corresponding to the received drug code from the pharmaceutical component database, and reads the risk level corresponding to each of the read component codes from the risk database;
An information display unit for displaying the read degree of risk on a display device;
A pharmaceutical sales support system characterized by comprising: The pharmaceutical sales support system according to claim 1,
The risk acquisition unit reads the highest risk degree corresponding to each of the component codes,
Pharmaceutical sales support system characterized by The pharmaceutical sales support system according to claim 1,
A drug information database that stores drug description information that describes a description of the drug in association with the drug code;
A risk information database for storing risk explanation information describing an explanation of the risk of the drug for each risk degree; and
An explanation information acquisition unit that reads the explanation information corresponding to the received medicine code;
With
The risk acquisition unit reads the risk explanation information corresponding to the risk degree from the risk information database,
The information display unit displays the risk explanation information and the medicine explanation information;
Pharmaceutical sales support system characterized by The pharmaceutical sales support system according to claim 3,
A pharmaceutical sales support system comprising an information printing unit that outputs the risk explanation information and the medicine explanation information to a printing device. The pharmaceutical sales support system according to claim 1,
The sales medicine input unit accepts an input of a list including a plurality of the medicine codes,
A combination contraindication database for storing a contraindication drug code, which is the drug code that identifies the drug that is contraindicated for use in combination with the drug specified by the drug code, in association with the drug code;
For each of the drug codes included in the list, the contraindicated drug code corresponding to the drug code is read from the combined contraindication database, and the combined contraindication for determining whether the read incompatible drug code is included in the list A determination unit;
When the list of contraindicated medicine codes is included in the list, the display device displays a message indicating that the combination of the medicine specified by the medicine code and the medicine specified by the contraindicated medicine code is contraindicated. A contraindication message display section to be displayed on,
A pharmaceutical sales support system characterized by comprising: The pharmaceutical sales support system according to claim 5,
The combination contraindication determination unit reads out and reads a reverse contraindication ID, which is the drug code corresponding to the contraindication drug code matching the drug code, from the combination contraindication database for each of the drug codes included in the list. Determining whether the contraindication ID is included in the list;
The combination contraindication message display unit displays the combination contraindication message even when the reverse contraindication ID is included in the list;
Pharmaceutical sales support system characterized by A method for supporting the sale of pharmaceuticals,
An information processing apparatus including a CPU and a memory is provided.
In association with a drug code for specifying the drug, a component code for specifying a component contained in the drug is stored in the memory,
In association with the component code, the risk level indicating the risk level of the drug containing the component is stored in the memory,
Accept the entry of the drug code that identifies the drug for sale,
Reading the component code corresponding to the received medicine code from the memory, reading the risk level corresponding to each of the read component code from the memory,
Displaying the read degree of risk on a display device;
A pharmaceutical sales support method characterized by A program for supporting the sale of pharmaceuticals,
On the computer,
Associating with a drug code identifying the drug, storing a component code identifying a component included in the drug in a memory;
Storing in the memory a risk level indicating a risk level of the drug containing the component in association with the component code;
Receiving an input of the drug code identifying the drug to be sold;
Reading the component code corresponding to the received medicine code from the memory, and reading the risk level corresponding to each of the read component code from the memory;
Displaying the read degree of risk on a display device;
A program for running

Images